deltorphin ii, ala(2)- has been researched along with quinoxalines in 1 studies
| Studies (deltorphin ii, ala(2)-) | Trials (deltorphin ii, ala(2)-) | Recent Studies (post-2010) (deltorphin ii, ala(2)-) | Studies (quinoxalines) | Trials (quinoxalines) | Recent Studies (post-2010) (quinoxalines) |
|---|---|---|---|---|---|
| 233 | 0 | 20 | 9,887 | 625 | 3,095 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fairbanks, CA; Kitto, KF; Messing, RO; Overland, AC; Schuster, DJ; Stone, LS; Wilcox, GL | 1 |
1 other study(ies) available for deltorphin ii, ala(2)- and quinoxalines
| Article | Year |
|---|---|
Protein kinase Cε is required for spinal analgesic synergy between delta opioid and alpha-2A adrenergic receptor agonist pairs.
Topics: Adrenergic alpha-2 Receptor Agonists; Analgesics; Anesthesia, Spinal; Animals; Brimonidine Tartrate; Clonidine; Drug Synergism; Enzyme Inhibitors; Female; Immunohistochemistry; Isoenzymes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oligopeptides; Protein Kinase C-epsilon; Quinoxalines; Receptors, Adrenergic, alpha-2; Receptors, Opioid, delta; Spinal Cord | 2013 |